The effect of disease modifying therapies on fatigue in multiple sclerosis

•Fatigue is a symptom with a serious impact on patients’ quality of life.•Inclusion of fatigue as an RCT outcome is crucial to understand the impact of DMTs.•Limited RCTs of DMTs assessed fatigue as an outcome.•The reporting of PROs of DMT trials assessing fatigue is suboptimal.•Carefully considerat...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Multiple sclerosis and related disorders Ročník 79; s. 105065
Hlavní autori:	Cruz Rivera, Samantha, Aiyegbusi, Olalekan Lee, Piani Meier, Daniela, Dunne, Achille, Harlow, Danielle E, Henke, Christian, Kamudoni, Paul, Calvert, Melanie J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands Elsevier B.V 01.11.2023
Predmet:	Disease-modifying therapies (DMTs) Fatigue Fatigue - drug therapy Fatigue - etiology Humans Multiple Sclerosis - complications Multiple Sclerosis - therapy Neurology Patient Reported Outcome Measures Patient-reported outcomes (PROs) Reference Standards Systematic Reviews as Topic Fatigue Patient-reported outcomes (PROs) Disease-modifying therapies (DMTs) patient-reported outcomes (PROs) fatigue disease-modifying therapies (DMTs)
ISSN:	2211-0348, 2211-0356, 2211-0356
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!